Neurology Journal
Fecha de publicación: 19 de noviembre de 2021
Autores: Alice Gravier Dumonceau, Roxana Ameli, Veronique Rogemond, Anne Ruiz, Bastien Joubert, Sergio Muñiz-Castrillo, Alberto Vogrig, Geraldine Picard, Aditya Ambati, Marie Benaiteau, Florence Rulquin, Jonathan Ciron, Kumaran Deiva, Thomas de Broucker, Laurent Kremer, Philippe Kerschen, François Sellal, Bastien Bouldoires, Roxana Genet, Jonathan Biberon, Adrien Bigot, Fanny Duval, Nahema Issa, Elena-Camelia Rusu, Mathilde Goudot, Anais Dutray, Jean Louis Devoize, Lucie Hopes, Anne-Laure Kaminsky, Marion Philbert, Eve Chanson, Amelie Leblanc, Erwan Morvan, Daniela Andriuta, Philippe Diraison, Gabriel Mirebeau, Celine Derollez, Veronique Bourg, Quentin Bodard, Clementine Fort, Irina Grigorashvili-Coin, Guillaume Rieul, Daniela Molinier-Tiganas, Mickaël Bonnan, Thierry Tchoumi, Jérôme Honnorat, Romain Marignier
DOI: https://doi.org/10.1212/WNL.0000000000013087
Objectives: To report the clinical, biological, imaging features, and the clinical course of a French cohort of patients with glial fibrillar acidic protein (GFAP) autoantibodies.
